SUNRISE, Fla., Jan. 14, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (OTCBB:BHRT) (http://www.bioheartinc.com) today announced it is one of the presenters at the upcoming Phacilitate 7th Annual Cell & Gene Therapy Forum in Washington D.C. from January 24th – 26th. The 3 day conference program will feature a hybrid of business, regulatory and scientific topics, with speakers drawn from pharmaceutical and biotech companies, the regulators and cell and gene therapy developers.
